AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+8.91%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
+$149M
(-15%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-23.3%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
297
New
63
Increased
40
Reduced
80
Closed
81
Top Buys
| 1 |
ABVX
Abivax
ABVX
|
$2.86M |
| 2 |
Pfizer
PFE
|
$2.3M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
$2.1M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$1.93M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$3.38M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$2.95M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$2.78M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$2.74M |
| 5 |
TSVT
2seventy bio
TSVT
|
$2.58M |
Sector Composition
| 1 | Healthcare | 59.47% |
| 2 | Real Estate | 11.94% |
| 3 | Financials | 4.93% |
| 4 | Industrials | 2.46% |
| 5 | Consumer Discretionary | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rithm Capital
RITM
$6.57B
| $4.28M | 2.87% | 400,966 -106,311 | -21% | -$1.14M |
|
2
Galapagos
GLPG
$2.07B
| $4.27M | 2.87% | 105,000 | – | – |
|
3
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.04M | 2.71% | 675,000 +26,000 | +4% | +$156K |
|
4
Pacira BioSciences
PCRX
$1.2B
| $3.96M | 2.66% | 117,500 +14,500 | +14% | +$489K |
|
5
Harmony Biosciences
HRMY
$2.12B
| $3.94M | 2.65% | 122,000 | – | – |
|
6
Embecta
EMBC
$847M
| $3.79M | 2.54% | 200,000 -7,000 | -3% | -$133K |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $3.78M | 2.54% | 127,500 +65,000 | +104% | +$1.93M |
|
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.33M | 2.24% | 1,000,000 +87,500 | +10% | +$291K |
|
|
WBA
9
DELISTED
Walgreens Boots Alliance
WBA
| $3.13M | 2.1% | 120,000 -105,000 | -47% | -$2.74M |
|
10
argenx
ARGX
$43.6B
| $2.95M | 1.98% | 7,750 +5,000 | +182% | +$1.9M |
|
|
ABVX
11
Abivax
ABVX
$6.12B
| $2.86M | 1.92% | +267,500 | New | +$2.86M |
|
12
uniQure
QURE
$896M
| $2.85M | 1.91% | 421,025 +29,525 | +8% | +$200K |
|
|
EFC
13
Ellington Financial
EFC
$1.36B
| $2.82M | 1.89% | 221,602 -17,669 | -7% | -$225K |
|
14
Ironwood Pharmaceuticals
IRWD
$214M
| $2.8M | 1.88% | 245,000 -47,500 | -16% | -$543K |
|
15
UroGen Pharma
URGN
$900M
| $2.33M | 1.56% | 155,000 -10,000 | -6% | -$150K |
|
|
16
Pfizer
PFE
$141B
| $2.3M | 1.55% | +80,000 | New | +$2.3M |
|
|
DX
17
Dynex Capital
DX
$1.64B
| $2.27M | 1.53% | 181,492 | – | – |
|
18
Amylyx Pharmaceuticals
AMLX
$836M
| $2.22M | 1.49% | 151,000 +5,500 | +4% | +$81K |
|
|
19
Invesco NASDAQ 100 ETF
QQQM
$58.8B
| $2.1M | 1.41% | +12,478 | New | +$2.1M |
|
|
20
Invesco QQQ Trust
QQQ
$364B
| $2.1M | 1.41% | +5,122 | New | +$2.1M |
|
21
Amicus Therapeutics
FOLD
$2.34B
| $1.99M | 1.33% | 140,000 +7,500 | +6% | +$106K |
|
|
RVNC
22
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.93M | 1.3% | 220,000 +30,000 | +16% | +$264K |
|
23
DocGo
DCGO
$153M
| $1.73M | 1.16% | 310,000 +302,500 | +4,033% | +$1.69M |
|
|
NYMT
24
New York Mortgage Trust
NYMT
$652M
| $1.71M | 1.15% | 200,963 | – | – |
|
25
Medtronic
MDT
$119B
| $1.69M | 1.13% | 20,500 +16,500 | +413% | +$1.36M |
|